Unicycive Therapeutics, Inc. (UNCY)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-87.9%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | — | — | $675.0K | $951.0K | — | — | — |
| Operating Income | -$29.52M | -$32.12M | -$20.77M | -$18.05M | -$8.98M | -$2.02M | — |
| Net Income | -$26.55M | -$36.73M | -$30.54M | -$18.06M | -$10.02M | -$2.26M | — |
| EPS (Diluted) | $-1.67 | $-5.65 | $-1.28 | $-1.20 | $-0.86 | $-0.27 | — |
| Total Assets | $49.13M | $31.67M | $14.19M | $2.82M | $18.74M | $204.0K | — |
| Total Liabilities | $18.94M | $24.24M | $18.00M | $3.28M | $2.26M | $2.88M | — |
| Shareholders' Equity | $30.20M | $7.43M | -$3.81M | -$466.0K | $16.48M | -$2.67M | -$884.0K |
| Cash & Equivalents | $29.20M | $26.14M | — | $455.0K | $16.58M | — | — |
| Operating Cash Flow | -$31.32M | -$28.57M | -$18.28M | -$15.65M | -$5.77M | -$1.46M | — |
| Capital Expenditures | $24.0K | $72.0K | $12.0K | $2.0K | $29.0K | — | — |
| Shares Outstanding | 22.11M | 11.38M | 34.76M | 15.23M | 15.00M | 8.51M | — |